Novartis, Bristol Myers pause CAR-T trials
Novartis and Bristol Myers Squibb have paused clinical trials for CAR-T cell therapies targeting autoimmune disorders following patient deaths, raising safety concerns for a promising new medical era.
Keep reading this one
You've read the thesis and who argued it. A free account opens the argument, what validates it, the risks the show raised, and the moment in the episode where it was said — 3 ideas in full a day, no card.